Transcat Announces Fourth Quarter and Full Fiscal Year 2021 Conference Call and Webcast
Transcat, Inc. (Nasdaq: TRNS) announced it will release its fourth quarter and fiscal year 2021 results on May 18, 2021, after market close. The company will host a conference call on May 19, 2021, at 11:00 a.m. ET to discuss its financial performance and corporate strategy. Transcat provides accredited calibration, repair, and inspection services across various industries, with a focus on life sciences, aerospace, and utilities. Its dual operating segments enhance its service and distribution capabilities, aiming for organic growth and market expansion through acquisitions.
- Potential for organic sales growth through enhanced service capabilities.
- Strategic focus on expanding its addressable calibration market via acquisitions.
- None.
Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its fourth quarter and full fiscal year 2021 results after the close of financial markets on Tuesday, May 18, 2021.
The Company will host a conference call and webcast to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow.
Fourth Quarter and Fiscal Year 2021 Conference Call
Wednesday, May 19, 2021
11:00 a.m. Eastern Time
Phone: (201) 689-8471
Webcast and accompanying slide presentation: www.transcat.com/investor-relations
A telephonic replay will be available from 2:00 p.m. ET on the day of the teleconference call until Wednesday, May 26, 2021. To listen to the archived call, dial (412) 317-6671 and enter conference ID number 13718348, or access the webcast replay at www.transcat.com/investor-relations, where a transcript will be posted once available.
ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses; as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 22 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada, and services at 20 imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.
Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise and integrity create a unique and compelling value proposition for its customers.
Transcat’s strategy is to leverage the complementary nature of its two operating segments, its comprehensive service capabilities, strong brand, enhanced e-commerce capabilities and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.
More information about Transcat can be found at: Transcat.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210505005737/en/
FAQ
What are the date and time for Transcat's Q4 and fiscal year 2021 earnings release?
When will Transcat hold its conference call?
How can I access Transcat's conference call?
What sectors does Transcat cater to?
What is Transcat's business strategy?
